criteria for semaglutide Key eligibility STEP trials Who Qualifies for Semaglutide GLP-1

Range of motion during daily activities increases

Although rare, alpha-lipoic acid may cause insulin autoimmunity (see Concerns and Cautions)

Dysautonomia can be mild or debilitating

Asset forfeiture is controversial at times, though not uncommon

Resources Novo Nordisk Wegovy prescribing information FDA Foundayo approval information Eli Lilly Foundayo / orforglipron clinical trial information ClinicalTrials.gov ATTAIN-1 and ATTAIN-2 trial records NICE obesity and weight-management guidance NHS healthy weight and specialist weight-management information General Pharmaceutical Council guidance on checking registered online pharmacies MHRA safety advice on buying medicines online and avoiding counterfeit medicines